Received Apr 17, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (PFIZER-BIONTECH)) | PFIZER\BIONTECH | 3 | — | — |
He's had three shots. We use Pfizer/ both got Covid; He's had three shots. We use Pfizer/ both got Covid; This is a spontaneous report received from a Consumer or other non HCP, Program ID. A 63-year-old male patient received BNT162b2 (BNT162B2 NOS), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown) and as dose 3 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "cancer patient" (ongoing); "very low immune system" (ongoing); "Covid-19", start date: 2023 (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset Jan2024, outcome "unknown" and all described as "He's had three shots. We use Pfizer/ both got Covid". Therapeutic measures were taken as a result of drug ineffective, covid-19.
Cancer; Immune system disorder
Medical History/Concurrent Conditions: COVID-19